PDF(Pubmed)
Abstract：
This is a case report of a 76-year-old Filipino male who presented with a six-year history of a steadily growing left breast mass. The mass was eventually diagnosed to be Invasive Ductal Carcinoma, Anatomic and Prognostic Stage IIIB (T4b cN0 M0), Grade 3, Luminal A. Subsequently, the patient underwent neoadjuvant chemotherapy of doxorubicin/cyclophosphamide and paclitaxel, followed by modified radical mastectomy with axillary lymph node dissection, concluded by post-mastectomy radiation therapy. The patient had complete clinical response to this trimodality therapy. The rarity of this case is juxtaposed and integrated with the present literature on male breast cancer.
摘要：
这是一名76岁的菲律宾男性的病例报告，他有六年的左乳房肿块稳步增长的历史。该肿块最终被诊断为浸润性导管癌，解剖和预后IIIB期（T4bcN0M0），三级，管腔A，随后，患者接受了阿霉素/环磷酰胺和紫杉醇的新辅助化疗，然后进行改良根治术和腋窝淋巴结清扫术，通过乳房切除术后放射治疗结束。患者对这种三联疗法有完全的临床反应。这种情况的罕见性与男性乳腺癌的现有文献并列并结合。
